BridgeBio has secured FDA Priority Review for its oral infigratinib [...]

Novadip Biosciences has secured €10.4 million in convertible financing to [...]

Andelyn Biosciences is manufacturing Ultragenyx’s newly FDA-approved Fayuvi gene therapy [...]

A US National Institutes of Health grant will fund an [...]

The FDA has cleared Sapience Therapeutics to begin clinical development [...]

Genespire has started enrolling children with severe methylmalonic acidemia in [...]

The FDA has accepted Belite Bio’s application for tinlarebant and [...]

Vaderis Therapeutics has raised $152M and started a global Phase [...]

Zilucoplan has been accepted for restricted use in NHS Scotland [...]

Grifols has completed patient follow-up in its Phase 3 SPARTA [...]